BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26878133)

  • 1. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.
    Yu PY; Balkhi MY; Ladner KJ; Alder H; Yu L; Mo X; Kraybill WG; Guttridge DC; Iwenofu OH
    Lab Invest; 2016 Apr; 96(4):481-91. PubMed ID: 26878133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
    Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
    Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profiling of primary high-grade soft tissue sarcomas.
    Renner M; Czwan E; Hartmann W; Penzel R; Brors B; Eils R; Wardelmann E; Büttner R; Lichter P; Schirmacher P; Mechtersheimer G
    Genes Chromosomes Cancer; 2012 Nov; 51(11):982-96. PubMed ID: 22811003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
    Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
    Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of altered MicroRNA expression patterns in synovial sarcoma.
    Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
    Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a blood-borne miRNA signature of synovial sarcoma.
    Fricke A; Ullrich PV; Heinz J; Pfeifer D; Scholber J; Herget GW; Hauschild O; Bronsert P; Stark GB; Bannasch H; Eisenhardt SU; Braig D
    Mol Cancer; 2015 Aug; 14():151. PubMed ID: 26250552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
    Tanriverdi O; Yildiz A
    J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.
    Italiano A; Di Mauro I; Rapp J; Pierron G; Auger N; Alberti L; Chibon F; Escande F; Voegeli AC; Ghnassia JP; Keslair F; Laé M; Ranchère-Vince D; Terrier P; Baffert S; Coindre JM; Pedeutour F
    Lancet Oncol; 2016 Apr; 17(4):532-538. PubMed ID: 26970672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.
    Kapodistrias N; Mavridis K; Batistatou A; Gogou P; Karavasilis V; Sainis I; Briasoulis E; Scorilas A
    Oncotarget; 2017 Jan; 8(4):6896-6913. PubMed ID: 28036291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma.
    Fricke A; Cimniak AFV; Ullrich PV; Becherer C; Bickert C; Pfeifer D; Heinz J; Stark GB; Bannasch H; Braig D; Eisenhardt SU
    Cancer Biomark; 2018; 22(2):199-207. PubMed ID: 29689704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study.
    Hill DA; O'Sullivan MJ; Zhu X; Vollmer RT; Humphrey PA; Dehner LP; Pfeifer JD
    Am J Surg Pathol; 2002 Aug; 26(8):965-77. PubMed ID: 12170083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipomatous tumors.
    Weiss SW
    Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.
    Meis-Kindblom JM; Sjögren H; Kindblom LG; Peydró-Mellquist A; Röijer E; Aman P; Stenman G
    Virchows Arch; 2001 Aug; 439(2):141-51. PubMed ID: 11561754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
    Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
    Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
    Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
    Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
    Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
    Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.